Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients

PHASE4WithdrawnINTERVENTIONAL

Timeline

Start Date

September 30, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

May 10, 2010

Conditions

Heparin-Induced ThrombocytopeniaHeparin-induced Thrombocytopenia and Thrombosis Syndrome

Interventions

DRUG

bivalirudin

Bivalirudin; 0.75mg/kg/h IV bolus followed immediately by 1.75 mg/kg/h infusion for the duration of the procedure

Trial Locations (1)

Duke Clinical Research Institute, Durham